The Global Platform for Access to Childhood Cancer Medicines (Global Platform) is entering a critical phase of growth and is assessing how best to expand and strengthen its technical and operational capacities to ensure sustained access to quality-assured childhood cancer medicines. While the Global Platform’s current operation model relies on a strong partnership foundation, the Global Platform recognizes the need to refine and potentially broaden this collaborative structure as demand increases and country engagement deepens. To support this evolution, the Global Platform seeks to better understand the range of capabilities, technical expertise, and partnership models available across countries, regions and the global health landscape. Augmenting the impact of the Global Platform could take the form of deepened partnerships with the organizations that are currently part of the Global Platform, introducing new partners, and/or contracting of organizations to provide certain targeted services. To support this progress, the Global Platform is soliciting expressions of interest (EOIs) from qualified organizations as detailed in the Call for EOI documentation attached.